Concepedia
Author
Laura McBride
Also Known As
L.H. McBride, Laura McBride
28
Publications
589
Citations
11
H-Index
0
Concepts
All Affiliations
×
All Concepts
533
10
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma
Paul G. Richardson, Constantine Mitsiades, Kathleen Colson, +11
Leukemia & lymphoma/Leukemia and lymphoma
2008
191
Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib
Paul G. Richardson, David S. Siegel, Rachid Baz, +19
Blood
2012
161
A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or in Combination with Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib.
Paul Richardson, David S. Siegel, Rachid Baz, +9
2009
39
Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
David H. Vesole, Elizabeth Bilotti, Joshua Richter, +13
British Journal of Haematology
2015
35
Dextromethorphan ameliorates effects of neonatal hypoxia on brain morphology and seizure threshold in rats
Nirupama Laroia, Laura McBride, Raymond B. Baggs, +1
Developmental Brain Research
1997
Final Results of a Phase I Trial of Oral Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Patients with Advanced Multiple Myeloma.
Paul G. Richardson, Constantine S. Mitsiades, Kathleen Colson, +11
2007
18
The Anion Gap and Routine Serum Protein Measurements in Monoclonal Gammopathies
Karen H. van Hoeven, Rosy E. Joseph, William J. Gaughan, +6
Clinical Journal of the American Society of Nephrology
2011
14
Inaccuracies in 24-Hour Urine Testing for Monoclonal Gammopathies
D. S. Siegel, Laura McBride, Elizabeth Bilotti, +7
Laboratory Medicine
Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple Myeloma,
Joshua R. Richter, Elizabeth Bilotti, Laura McBride, +9
12
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide‐containing regimens
Larysa Sanchez, David H. Vesole, Joshua Richter, +6
2016
Page 1